Biospectal - About the company
Biospectal is a seed company based in Lausanne (Switzerland), founded in 2017 by Peter Dolch. It operates as an App based optical analysis platform for blood pressure monitoring. Biospectal has raised $4.3M in funding from Seedlink. The company has 220 active competitors, including 37 funded and 7 that have exited. Its top competitors include companies like Microlife, Oxehealth and Valencell.
Company Details
Biospectal has developed an app based optical analysis platform for blood pressure monitoring and management. In this platform, the optical analysis is done using the camera in smartphones to measure blood pressure through the fingertip.
- Website
- biospectal.com
- Email ID
- *****@biospectal.com
Key Metrics
Founded Year
2017
Location
Lausanne, Switzerland
Stage
Seed
Total Funding
$4.3M in 1 round
Latest Funding Round
Ranked
28th among 220 active competitors
Employee Count
5 as on Aug 31, 2026
Sign up to download Biospectal's company profile
Biospectal's funding and investors
Biospectal has raised a total funding of $4.3M over 1 round. Its latest funding round was a Seed round on Jul 21, 2021 for $*****. 4 investors participated in its latest round. Biospectal has 8 institutional investors.
Here is the list of recent funding rounds of Biospectal:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 21, 2021 | 3215177 | Seed | 2022801 | 9087984 | 2124306 | 4203289 |
View details of Biospectal's funding rounds and investors
Biospectal's founders and board of directors
Founder? Claim ProfileThe founders of Biospectal is Peter Dolch.
Here are the details of Biospectal's key team members:
- Peter Dolch: Founder of Biospectal and founder of 4 other companies, including Manticor, Tgix and PSYBER.
View details of Biospectal's Founder profiles and Board Members
Biospectal's employee count trend
Biospectal has 5 employees as of Aug 26. Here is Biospectal's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biospectal's Competitors and alternates
Top competitors of Biospectal include Microlife, Oxehealth and Valencell. Here is the list of Top 10 competitors of Biospectal, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Portfolio of thermometers and blood pressure monitors | - | 56/100 | ||
2nd | Oxehealth 2012, Leeds (United Kingdom), Series A | Provider of contactless patient monitoring platform for mental health facilities | $7.14M | 51/100 | |
3rd | Valencell 2006, Raleigh (United States), Series E | Developer of based medical sensors for monitoring body vitals | $37.6M | 49/100 | |
4th | Riva Health 2013, Denver (United States), Series A | Mobile-based application for monitoring blood pressure | $39.2M | 47/100 | |
5th | Copilot IQ 2021, Nashville (United States), Seed | Provider of at-home diabetes and blood pressure monitoring solutions | - | 46/100 | |
6th | Vectorious Medical Tech 2011, Tel Aviv (Israel), Acquired | Implant for left-atrial monitoring | $14.3M | 45/100 | |
7th | AVAX Blood Pressure 2020, Dusseldorf (Germany), Unfunded | Provider of blood pressure monitoring and tracking app | - | - | 45/100 |
8th | Vena Vitals 2019, Irvine (United States), Seed | Provider of wearable sticker for monitoring blood pressure | - | 44/100 | |
9th | Quanttus 2012, Cambridge (United States), Deadpooled | Wearable and mobile app to monitor blood pressure | $22M | 44/100 | |
10th | SmartBP 2012, Minneapolis (United States), Unfunded | Provider of blood pressure tracker app for patients | - | - | 44/100 |
28th | Biospectal 2017, Lausanne (Switzerland), Seed | App based optical analysis platform for blood pressure monitoring | $4.3M | 37/100 |
Looking for more details on Biospectal's competitors? Click here to see the top ones
Biospectal's Investments and acquisitions
Biospectal has made no investments or acquisitions yet.
Reports related to Biospectal
Here is the latest report on Biospectal's sector:
News related to Biospectal
•
Biospectal receives first-ever CE Mark for a smartphone blood pressure monitoring appStartupticker•Dec 07, 2023•Biospectal
•
Global Health Study Validates Biospectal OptiBP Mobile Blood Pressure Measurement App Accuracy Across Diverse SettingsBusiness Wire•May 25, 2023•Biospectal
•
Biospectal Partners with Amref Health Africa to Extend Global Access to Blood Pressure ManagementBusiness Wire•Oct 06, 2022•Biospectal, Amref
•
Biospectal OptiBP Named Winner in Fast Company’s First-Ever List of the Next Big Things in TechPRWeb•Nov 19, 2021•Biospectal
•
Biospectal OptiBP Honored in Fast Company’s 2021 Innovation by Design AwardsPRWeb•Oct 01, 2021•Biospectal
•
Biospectal Initiates Studies of its Blood Pressure Measurement AppMedical Product Outsourcing•Jul 28, 2021•Biospectal
•
Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLinkPR Newswire•Jul 21, 2021•Biospectal, Privilege Ventures, Athensmed, LabCorp and 3 others
•
OptiBP app for iOS launched at MWC by Biospectal offering medical grade blood pressure monitoringIoT Now•Jul 01, 2021•Biospectal
•
•
Biospectal announces public beta launch of optiBP™ for Android at CES 2021IoT Now•Jan 11, 2021•Biospectal
Are you a Founder ?
FAQs about Biospectal
Explore our recently published companies
- Zhuconstruction - Unfunded company
- Zealdevgroup - 2023 founded, Unfunded company
- Thewineovator - Unfunded company
- General Electric - Cincinnati based, 1892 founded, Acquired company
- Soller-Law - Unfunded company
- Smcfacade - Unfunded company
